Messages in brief
Clinical studies and the war in Ukraine
messages in brief
|
05/04/2022
Clinical studies and the war in Ukraine - Information for Consumers.
Clinical studies and the war in Ukraine
Read more
Clinical studies and the war in Ukraine
messages in brief
|
05/04/2022
Clinical studies and the war in Ukraine - Information for Healthcare Professionals.
Clinical studies and the war in Ukraine
Read more
Current issue of “RMS NEWS”
messages in brief
|
31/03/2022
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS”
Read more
Online-Form: Side effects veterinary drugs
messages in brief
|
18/02/2022
Reporting suspected adverse reactions to veterinary drugs is possible using an online form.
Online-Form: Side effects veterinary drugs
Read more
Amendments to the AMG (Austrian Medicines Act, Arzneimittelgesetz) concerning notifications of discontinuation of placing on the market
messages in brief
|
14/02/2022
With the AMG amendment of 14.02.2022, § 21(2) was changed to the effect that the BASG must now be notified four months (instead of the previous two months) in advance of a temporary or permanent discontinuation of the marketing of medicinal products.
Amendments to the AMG (Austrian Medicines Act, Arzneimittelgesetz) concerning notifications of discontinuation of placing on the market
Read more
BASG information concerning the new Veterinary Medicinal Products Regulation
messages in brief
|
07/02/2022
The new Veterinary Medicinal Products Regulation is to be applied as of 28.01.2022.
BASG information concerning the new Veterinary Medicinal Products Regulation
Read more
Current issue of “RMS NEWS”
messages in brief
|
31/01/2022
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS”
Read more
European System for Application and Surveillance of Clinical Trials online with 31.01.2022
messages in brief
|
31/01/2022
On Monday 31st January 2022 at 9:00 a.m. CET, the Clinical Trials Information System (CTIS) has gone live. CTIS is the backbone of the Clinical Trials Regulation that will harmonise the assessment and supervision of clinical trials in the EU and the EEA.
European System for Application and Surveillance of Clinical Trials online with 31.01.2022
Read more
COVID-19
messages in brief
|
16/12/2021
An overview of information by BASG to the novel Corona virus SARS-CoV-2 and the COVID-19 disease as well as links to websites with further information.
COVID-19
Read more
Follow-up meeting of PEI and AGES-MEA on future cooperation in the regulatory treatment of allergen products.
messages in brief
|
24/11/2021
Representatives of PEI and AGES-MEA again discussed national legal requirements and cooperation on allergens.
Follow-up meeting of PEI and AGES-MEA on future cooperation in the regulatory treatment of allergen products.
Read more